Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study.

BACKGROUND: Contemporary screening for prostate cancer frequently identifies small volume, low-grade lesions. Some clinicians have advocated focal prostatic ablation as an alternative to more aggressive interventions to manage these lesions. To identify which patients might benefit from focal ablati...

Täydet tiedot

Bibliografiset tiedot
Päätekijät:	Catto, J, Robinson, M, Albertsen, P, Goepel, JR, Abbod, M, Linkens, D, Davis, M, Rosario, D, Warren, A, Varma, M, Griffiths, D, Grigor, K, Mayer, N, Oxley, J, Deshmukh, N, Lane, J, Metcalfe, C, Donovan, J, Neal, D, Hamdy, F
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2011

Suitability of PSA-detected localised prostate cancers for focal therapy: Experience from the ProtecT study Tekijä Catto, J, Robinson, M, Albertsen, P, Goepel, JR, Abbod, M, Linkens, D, Davis, M, Rosario, D, Warren, A, Varma, M, Griffiths, D, Grigor, K, Mayer, N, Oxley, J, Deshmukh, N, Lane, J, Metcalfe, C, Donovan, J, Neal, D, Hamdy, F

Julkaistu 2011

Journal article

Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study.

Samankaltaisia teoksia